Related Experiment Videos
The cardiovascular effects of etilefrine
European Journal of Clinical Pharmacology
|January 1, 1975
Summary
Intravenous etilefrine boosts heart rate and blood pressure in healthy individuals. However, it causes significant cardiovascular changes when combined with propranolol, suggesting dual adrenergic effects.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
Background:
- Etilefrine is a sympathomimetic agent used to treat hypotension.
- Understanding its cardiovascular effects and interactions is crucial for clinical application.
Purpose of the Study:
- To investigate the cardiovascular effects of intravenous etilefrine in healthy individuals.
- To examine the impact of combining etilefrine with propranolol on cardiovascular parameters.
Main Methods:
- Healthy individuals received intravenous infusions of etilefrine at varying dosages.
- Cardiovascular parameters including pulse rate, cardiac output, stroke volume, central venous pressure, mean arterial pressure, and peripheral vascular resistance were monitored.
- The effects of etilefrine were also assessed after pretreatment with intravenous propranolol.
Main Results:
- Etilefrine administration led to increased pulse rate, cardiac output, stroke volume, central venous pressure, and mean arterial pressure.
- Peripheral vascular resistance initially decreased with lower etilefrine doses (1-8 mg) but increased at higher doses.
- Co-administration with propranolol resulted in significant reductions in pulse rate, cardiac output, stroke volume, and peripheral blood flow, alongside an increase in mean arterial pressure.
Conclusions:
- Etilefrine exhibits both beta-1 and alpha-adrenergic effects in humans.
- The combination of etilefrine and propranolol elicits distinct cardiovascular responses, highlighting the complex adrenergic interactions.